Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026GuruFocus · 2 hr ago
Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026Business Wire · 3 hr ago
4 High-Yield Dividends That Could Be Next on the Chopping Block24/7 Wall Street · 4 hr ago
Pfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might SeemThe Motley Fool · 11 hr ago
Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip24/7 Wall Street · 1 day ago
Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?The Motley Fool · 1 day agoPfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | $0.68 | $0.77 | Beat |
| May 5, 2026 | $0.72 | $0.75 | Beat |
| Feb 3, 2026 | $0.57 | $0.66 | Beat |
| Nov 4, 2025 | $0.63 | $0.87 | Beat |
| Aug 5, 2025 | $0.58 | $0.78 | Beat |
| Apr 29, 2025 | $0.67 | $0.92 | Beat |